en
Ben Goldacre

Bad Pharma

Benachrichtigen, wenn das Buch hinzugefügt wird
Um dieses Buch zu lesen laden Sie eine EPUB- oder FB2-Datei zu Bookmate hoch. Wie lade ich ein Buch hoch?
Ben Goldacre puts the $600bn global pharmaceutical industry under the microscope. What he reveals is a fascinating, terrifying mess. ***Now updated with the latest government responses to the book***
Doctors and patients need good scientific evidence to make informed decisions. But instead, companies run bad trials on their own drugs, which distort and exaggerate the benefits by design. When these trials produce unflattering results, the data is simply buried. All of this is perfectly legal. In fact, even government regulators withhold vitally important data from the people who need it most. Doctors and patient groups have stood by too, and failed to protect us. Instead, they take money and favours, in a world so fractured that medics and nurses are now educated by the drugs industry.
The result: patients are harmed in huge numbers.
Ben Goldacre is Britain’s finest writer on the science behind medicine, and ‘Bad Pharma’ is the book that finally prompted Parliament to ask why all trial results aren’t made publicly available — this edition has been updated with the latest news from the select committee hearings. Let the witty and indefatigable Goldacre show you how medicine went wrong, and what you can do to mend it.
Dieses Buch ist zurzeit nicht verfügbar
557 Druckseiten
Jahr der Veröffentlichung
2012
Haben Sie es bereits gelesen? Was halten sie davon?
👍👎

Ersteindruck

  • elleveldahat einen Ersteindruck geteiltvor 6 Jahren

    Great book that chages completely the notion of a modern medicine

Zitate

  • nitrushinahat Zitat gemachtvor 7 Jahren
    It feels as if some people, perhaps, view research as a game, where the idea is to get away with as much as you can, rather than to conduct fair tests of the treatments we use.
  • nitrushinahat Zitat gemachtvor 7 Jahren
    eighteen of the twenty-nine industry-funded trials presented a conclusion in the abstract that misrepresented the main outcome measure. All of the nonindustry-funded studies were fine
  • nitrushinahat Zitat gemachtvor 7 Jahren
    the CCSG trial found that aspirin was effective at preventing stroke and death in men, but not in women;30 as a result, women were under-treated for a decade, until further trials and overviews showed a benefit.

In Regalen

fb2epub
Ziehen Sie Ihre Dateien herüber (nicht mehr als fünf auf einmal)